At Dermagut, we focus on the interaction between gut health and dermatological conditions. Increasing scientific evidence suggests that fungal overgrowth, particularly involving Candida albicans, may contribute to the development or persistence of several chronic inflammatory skin disorders.
This article outlines the characteristics of Candida albicans, its immunological effects, and its potential involvement in diseases such as psoriasis, atopic dermatitis, and seborrheic dermatitis.
What Is Candida albicans?
Candida albicans is a polymorphic yeast that is part of the normal commensal flora in the gastrointestinal tract, oral mucosa, genitourinary tract, and skin. Under physiological conditions, it exists in balance with other microorganisms. However, under certain circumstances — such as microbiome disruption or immunosuppression — C. albicans can shift into an invasive, pathogenic state.
This transition is marked by:
-
Hyphal transformation, allowing tissue penetration
-
Biofilm formation, promoting persistence and antifungal resistance
-
Immune activation, particularly of pro-inflammatory pathways
Immune Activation and Inflammation
C. albicans is a strong inducer of the Th17 immune response, a pathway also centrally involved in autoimmune and chronic inflammatory skin conditions.
The fungus stimulates immune cells to release:
-
Interleukin-17 (IL-17)
-
Tumor necrosis factor-alpha (TNF-α)
-
Interleukin-6 (IL-6)
These cytokines are known to contribute to epidermal hyperplasia, keratinocyte dysfunction, and barrier impairment — mechanisms seen in conditions such as psoriasis and eczema.
Moreover, overgrowth of Candida albicans in the gut can lead to increased intestinal permeability ("leaky gut"), allowing microbial antigens to enter the bloodstream and further drive systemic inflammation.
Associated Skin Diseases
Psoriasis
-
Multiple studies have reported increased oral and intestinal colonization of Candida albicans in patients with psoriasis.
-
The overlap in Th17/IL-23 activation suggests that C. albicans may contribute to the immunopathology of psoriatic disease.
-
Some clinical evidence points to elevated levels of anti-Candida antibodies (IgG, IgA) in psoriatic patients, suggesting chronic exposure.
Atopic Dermatitis (Eczema)
-
In atopic individuals, C. albicans may contribute to IgE-mediated hypersensitivity, leading to skin inflammation.
-
Skin barrier defects may facilitate fungal colonization, while gut dysbiosis involving Candida may exacerbate systemic immune dysregulation.
Seborrheic Dermatitis
-
Although Malassezia species are primarily implicated, co-infection or overgrowth of C. albicans — particularly in immunocompromised individuals — may worsen clinical presentation.
-
Dysbiosis involving both cutaneous and intestinal fungi could play a role in more severe or treatment-resistant forms.
Clinical Clues Suggesting Candida Involvement
While Candida albicans is not the sole cause of any skin disease, its presence as a contributing factor may be suspected in cases where inflammatory skin symptoms are accompanied by:
-
Recurrent oral or genital candidiasis
-
Gastrointestinal complaints (e.g., bloating, gas, altered bowel habits)
-
Cravings for carbohydrates or sugar
-
Persistent skin flares despite standard treatment
-
Evidence of mucosal dysbiosis or confirmed intestinal Candida overgrowth
Conclusion
Candida albicans is a well-adapted fungal organism capable of modulating immune responses and altering epithelial integrity. While its presence in the human body is normal and often harmless, under certain conditions it may become pathogenic and contribute to chronic inflammatory processes — including those affecting the skin.
Its role in conditions such as psoriasis, eczema, and seborrheic dermatitis highlights the importance of a broader, systemic perspective when evaluating skin disease. Investigating underlying microbial imbalances — particularly involving fungal species — may provide valuable insight into persistent or treatment-resistant dermatological presentations.